colorectal cancer |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
head and neck squamous cell carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
uterine corpus endometrial carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
urinary bladder urothelial carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
uterine carcinosarcoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
lung squamous cell carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
cervix carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
skin melanoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
gastric adenocarcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
ovarian serous cystadenocarcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
esophageal carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
chronic lymphocytic leukemia |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|